Opthea Ltd — Director's Dealing 2014

Dec 22, 2014

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Circadian Technologies Limited

ABN 32 006 340 567

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Megan Baldwin

Date of last notice 19 November 2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	22 December 2014
No. of securities held prior to change	33,674 ordinary shares fully paid. 11,500 listed options, exercise price $0.27, expiry 25 November 2018. 200,000 Employee conditional performance rights (unlisted securities) exercise price $Nil, expiry 31 March 2015.
Class	Ordinary shares, fully paid, listed options and performance rights (unlisted securities) and share options (unlisted securities).
Number acquired	1,500,000 options (unlisted securities) to purchase ordinary shares, exercise price $Nil, exercise period commencing on 25 May 2015 expiring on 25 May 2018 subject to vesting and exercise conditions.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	NIL
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$NIL
No. of securities held after change	33,674 ordinary shares fully paid. 11,500 listed options, exercise price $0.27, expiry 25 November 2018. 200,000 Employee conditional performance rights (unlisted securities) exercise price $Nil, expiry 31 March 2015. 1,500,000 share options (unlisted securities), exercise price $Nil, expiry 25 May 2018.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Share options granted under the company’s Long Term Incentive Plan and pursuant to a members’ resolution passed at the 2014 AGM.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
**Interest after change **	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	N0
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011